Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions

BMC Med Res Methodol. 2001:1:3. doi: 10.1186/1471-2288-1-3. Epub 2001 Jun 4.

Abstract

Background: Guidelines published in major medical journals are very influential in determining clinical practice. It would be essential to evaluate whether conflicts of interests are disclosed in these publications. We evaluated the reporting of conflicts of interest and the factors that may affect such disclosure in a sample of 191 guidelines on therapeutic and/or preventive measures published in 6 major clinical journals (Annals of Internal Medicine, BMJ, JAMA, Lancet, New England Journal of Medicine, Pediatrics) in 1979, 1984, 1989, 1994 and 1999.

Results: Only 7 guidelines (3.7%) mentioned conflicts of interest and all were published in 1999 (17.5% (7/40) of guidelines published in 1999 alone). Reporting of conflicts of interest differed significantly by journal (p=0.026), availability of disclosure policy by the journal (p=0.043), source of funding (p < 0.001) and number of authors (p=0.004). In the entire database of 191 guidelines, a mere 18 authors disclosed a total of 24 potential conflicts of interest and most pertained to minor issues.

Conclusions: Despite some recent improvement, reporting of conflicts of interest in clinical guidelines published in influential journals is largely neglected.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic* / legislation & jurisprudence
  • Clinical Trials as Topic* / methods
  • Clinical Trials as Topic* / standards
  • Conflict of Interest / legislation & jurisprudence*
  • Disclosure / legislation & jurisprudence
  • Disclosure / standards
  • Disclosure / trends
  • Humans
  • Periodicals as Topic / legislation & jurisprudence
  • Periodicals as Topic / standards
  • Periodicals as Topic / trends
  • Practice Guidelines as Topic*
  • Preventive Medicine*
  • Research Design / legislation & jurisprudence*